Amnestic mild cognitive impairment with low myocardial metaiodobenzylguanidine uptake

American Journal of Neurodegenerative Diseases

Volumn 1, Issue 2, 2012, Pages 146-151

  Sakakibara, Ryuji ^a   Ogata, Takeshi ^a   Haruta, Masayuki ^a   Kishi, Masahiko ^a   Tsuyusaki, Yohei ^a   Tateno, Akihiko ^a   Tateno, Fuyuki ^a   Mouri, Takayuki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Amnestic mild cognitive impairment; Dementia with Lewy bodies; Memory disorder; Metaiodobenzylguanidine (MIBG) myocardial scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE;

ADULT; AGED; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ARTICLE; BEHAVIOR DISORDER; BRAIN FUNCTION; COGNITION; CONSTIPATION; DRUG UPTAKE; FEMALE; FRONTAL ASSESSMENT BATTERY; FRONTAL FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY ASSESSMENT; MEMORY TEST; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MYOCARDIAL PERFUSION IMAGING; NOCTURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; REM SLEEP; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VERY ELDERLY; VISUAL HALLUCINATION; WECHSLER MEMORY SCALE;

EID: 84980052295     PISSN: None     EISSN: 2165591X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC,Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 2011; 7: 270-279.
3. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W; International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurol. 2004; 3: 19-28.
4. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM,Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB,Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK; DLB/PDD Working Group. DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007; 68: 812-819.
5. Hu XS, Okamura N, Arai H, Higuchi M, Matsui T, Tashiro M, Shinkawa M, Itoh M, Ido T, Sasaki H. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology. 2000; 55: 1575-1577.
6. Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 2007; 34: 939-950.
7. Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131: 642- 650.
8. Fujishiro H, Nakamura S, Kitazawa M, Sato K, Iseki E. Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using (123)I-MIBG cardiac scintigraphy. J Neurol Sci. 2011 Nov 28. [Epub ahead of print]
9. Folstein M, Folstein S, McHugh PR. Minimental state; a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975; 12: 189-198.
10. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 1356-1364.
11. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
12. Libb JW, Coleman JM. Correlations between the WAIS and revised Beta, Wechsler memory scale and Quick test in a vocational rehabilitation center. Psychol Rep. 1971; 29: 863-865.
13. Tateno F, Sakakibara R, Kishi M, Ogawa E, Terada H, Ogata T, Haruta H. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic. Parkinsonism Relat Disord 2011; 17: 395-397.
14. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004; 256: 240-246.
15. Del Tredici K, Duda JE. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases. J Neurol Sci. 2011; 310: 100-106.
16. Yoshida M, Fukumoto Y, Kuroda Y, Ohkoshi N. Sympathetic denervation of myocardium demonstrated by 123I-MIBG scintigraphy in pureprogressive autonomic failure. Eur Neurol 1997; 38: 291-296.
17. Tateno F, Sakakibara R, Kishi M, Ogawa E, Takada N, Hosoe N Suzuki Y, Takahashi M, Uchiyama T, Yamamoto T. Constipation and metaiodobenzylguanidine myocardial scintigraphy abnormality. J Am Geriatr Soc. 2012; 60: 185- 187.
18. Fujishiro H, Iseki E, Murayama N, Yamamoto R, Higashi S, Kasanuki K, Suzuki M, Arai H, Sato K. Diffuse occipital hypometabolism on 18 FFDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies? Psychogeriatrics 2010; 10: 144-152.
19. Kobayashi K, Sumiya H, Nakano H, Akiyama N, Urata K, Koshino Y. Detection of Lewy body disease in patients with late-onset depression, anxiety and psychoticdisorder with myocardial meta-iodobenzylguanidine scintigraphy. Int J Geriatr Psychiatry. 2010; 25: 55-65.
20. Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, Tangalos EG, Boeve BF, Knopman DS, Braak H, Petersen RC. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 2006; 63: 674-681.
21. Alexander I, Tröster A. Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers. Neuropsychol Rev 2008; 18: 103-119.
22. Markesbery WR. Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 2010; 19: 221-228.
23. Hanyu H, Sato T, Kume K, Takada Y, Onuma T, Iwamoto T. Differentiation of dementia with Lewy bodies from Alzheimer disease using the frontal assessment battery test. Int J Geriatr Psychiatry. 2009; 24: 1034-1035.
24. Tateno M, Kobayashi S, Saito T. Imaging improves diagnosis of dementia with Lewy bodies. Psychiatry Investig 2009; 6: 233-240.